Analyst Consensus ?
ConsensusBuy27 ratings
Bullish1970.4%
Neutral829.6%
Bearish00.0%
Zebra Technologies Corporation · ZBRA · FY2024 Q4 · Calendar Q1 2025
Zebra delivered a strong quarter but offered a cautious FY2025 outlook
The evidence is mixed: strong Q4 execution and continued AI, RFID, and machine-vision investment support the growth case, while modest FY2025 guidance and tariff, FX, and visibility risks limit confidence in near-term acceleration.
Reported Before market openNASDAQTechnology
$17.46B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $3.85
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus —
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-1.2%
Event window
SPY move
-0.4%
Same window
Abnormal move
-0.7%
Stock minus SPY
Volume
0.8×
Versus trailing sessions
Subsequent drift
-11.2%
Up to 20 sessions
ZBRASPY benchmark
Ask FN2 about ZBRA FY2024 Q4
Transcript, numbers and history already loaded
What drove ZBRA's -1.2% move after FY2024 Q4 earnings?What changed in ZBRA's guidance and outlook in FY2024 Q4?Give me the bull and bear case for ZBRA after FY2024 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The prior quarter emphasized raised expectations and broad-based momentum; the current analysis shows guidance maintained at a more modest FY2025 growth range, with tariffs and lower visibility more prominent while AI and machine vision remain strategic priorities.
Guidance delta
Management maintained guidance, with FY2025 sales growth expected at 3–7%, EBITDA margin at 21–22%, and free cash flow of at least $750 million.
Key takeaways
- Management highlighted AI-enabled hardware and software, RFID, and machine vision as growth initiatives.
- Tariff exposure and reduced visibility temper the outlook despite strong retail and healthcare demand.
- The Photoneo acquisition is intended to expand AI-driven machine-vision capabilities.
Management priorities
- Integrate Photoneo and expand AI-enabled products.
- Use pricing and supply-chain diversification to mitigate tariff pressure.
- Continue R&D investment in next-generation devices and AI capabilities.
Follow ZBRA with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$380.05Current
$260Low
$374.36Average
$500High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 19, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Neutral | Neutral | Maintain | Oct 12, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 12, 2026 |
| Truist Securities | Hold | Hold | Maintain | Oct 5, 2026 |
| Needham | Buy | Buy | Maintain | Sep 15, 2026 |
| TD Cowen | Buy | Buy | Maintain | Aug 5, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Aug 5, 2026 |
| BNP Paribas | Outperform | Outperform | Maintain | Aug 5, 2026 |
| Baird | Outperform | Outperform | Maintain | May 13, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 6, 2025 |
| UBS | Buy | Buy | Maintain | Apr 30, 2025 |
| Stephens & Co. | Overweight | Overweight | Maintain | Aug 2, 2024 |
| Exane BNP Paribas | Neutral | Underperform | Upgrade | Jun 13, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Apr 8, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 2, 2023 |
| JP Morgan | Overweight | Neutral | Upgrade | Apr 4, 2022 |
| Northcoast Research | Buy | Neutral | Upgrade | Mar 23, 2021 |
| Imperial Capital | Outperform | Outperform | Maintain | Nov 20, 2019 |
| Atlantic Equities | Overweight | Overweight | Maintain | Aug 27, 2019 |
| Berenberg | Buy | Buy | Maintain | Mar 7, 2019 |
| Wells Fargo | Market Perform | Market Perform | Maintain | Feb 27, 2018 |
| Wellington Shields | Buy | Hold | Upgrade | Nov 8, 2017 |
| CLSA | Buy | Buy | Maintain | Aug 3, 2016 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jun 8, 2016 |
| Avondale Partners | Perform | Market Perform | Maintain | Mar 28, 2016 |
| Oppenheimer | Outperform | Outperform | Maintain | Jan 20, 2016 |
| Barrington Research | Outperform | Outperform | Maintain | Aug 26, 2015 |
| Sidoti & Co. | Neutral | Buy | Downgrade | Jan 28, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $380.05. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Jamie Cook | $378 | $374.64 | -0.5% | Oct 5, 2026 |
| Needham | Robert Jamieson | $435 | $351.81 | +14.5% | Sep 15, 2026 |
| Truist Financial | Analyst unavailable | $355 | $373.87 | -6.6% | Aug 5, 2026 |
| Morgan Stanley | Meta Marshall | $360 | $373.76 | -5.3% | Aug 5, 2026 |
| KeyBanc | Analyst unavailable | $430 | $368.83 | +13.1% | Aug 5, 2026 |
| Barclays | Analyst unavailable | $410 | $368.83 | +7.9% | Aug 5, 2026 |
| Wolfe Research | Analyst unavailable | $317 | $271 | -16.6% | Jul 9, 2026 |
| Truist Financial | Analyst unavailable | $296 | $267.85 | -22.1% | Jul 2, 2026 |
| Barclays | Analyst unavailable | $346 | $245.69 | -9.0% | Jun 23, 2026 |
| Barclays | Guy Hardwick | $345 | $241.79 | -9.2% | May 13, 2026 |
| KeyBanc | Analyst unavailable | $305 | $241.79 | -19.7% | May 13, 2026 |
| Robert W. Baird | Analyst unavailable | $310 | $241.79 | -18.4% | May 13, 2026 |
| Truist Financial | Jamie Cook | $256 | $236.14 | -32.6% | Apr 20, 2026 |
| UBS | Damian Karas | $335 | $268.88 | -11.9% | Feb 13, 2026 |
| Barclays | Analyst unavailable | $330 | $274.15 | -13.2% | Feb 13, 2026 |
| Morgan Stanley | Meta Marshall | $323 | $274.15 | -15.0% | Feb 12, 2026 |
| Barclays | Guy Hardwick | $351 | $241.08 | -7.6% | Feb 6, 2026 |
| Barclays | Guy Hardwick | $368 | $259.48 | -3.2% | Jan 12, 2026 |
| Truist Financial | Jamie Cook | $291 | $254.22 | -23.4% | Dec 18, 2025 |
| Truist Financial | Analyst unavailable | $331 | $275.96 | -12.9% | Oct 29, 2025 |
| Barclays | Analyst unavailable | $360 | $274.31 | -5.3% | Oct 29, 2025 |
| Truist Financial | Analyst unavailable | $350 | $296.64 | -7.9% | Oct 8, 2025 |
| Barclays | Analyst unavailable | $375 | $296.64 | -1.3% | Oct 7, 2025 |
| Barclays | Tim Long | $301 | $302.6 | -20.8% | Aug 5, 2025 |
| UBS | Damian Karas | $425 | $318.36 | +11.8% | Feb 18, 2025 |
| Robert W. Baird | Analyst unavailable | $380 | $331.08 | -0.0% | Feb 18, 2025 |
| Truist Financial | Jamie Cook | $383 | $384.68 | +0.8% | Oct 29, 2024 |
| Robert W. Baird | Richard Eastman | $375 | $348.12 | -1.3% | Jul 31, 2024 |
| Truist Financial | Jamie Cook | $345 | $348.12 | -9.2% | Jul 31, 2024 |
| BNP Paribas | Andrew Buscaglia | $305 | $304.56 | -19.7% | Jun 13, 2024 |
| Needham | James Ricchiuti | $370 | $323.87 | -2.6% | May 16, 2024 |
| Robert W. Baird | Richard Eastman | $330 | $314.56 | -13.2% | May 1, 2024 |
| Stephens | Tommy Moll | $380 | $314.56 | -0.0% | May 1, 2024 |
| Wolfe Research | Brad Hewitt | $337 | $290.38 | -11.3% | Apr 8, 2024 |
| Truist Financial | Jamie Cook | $300 | $284.5 | -21.1% | Mar 13, 2024 |
| Needham | James Ricchiuti | $255 | $196.82 | -32.9% | Nov 1, 2023 |
| Morgan Stanley | Analyst unavailable | $260 | $270.82 | -31.6% | Dec 13, 2022 |
| Credit Suisse | Analyst unavailable | $319 | $258.1 | -16.1% | Dec 13, 2022 |
| UBS | Analyst unavailable | $495 | $325.44 | +30.2% | Aug 4, 2022 |
| Stephens | Analyst unavailable | $500 | $323.32 | +31.6% | Aug 3, 2022 |
| Needham | Analyst unavailable | $450 | $323.32 | +18.4% | Aug 3, 2022 |
| Needham | Analyst unavailable | $500 | $368.14 | +31.6% | May 4, 2022 |
| Morgan Stanley | Meta Marshall | $400 | $393.68 | +5.2% | Apr 16, 2022 |
| Wolfe Research | Brian Lau | $469 | $437.18 | +23.4% | Mar 20, 2022 |
| Needham | James Ricchiuti | $535 | $388.79 | +40.8% | Mar 10, 2022 |
Track every rating change on ZBRA the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationZebra Technologies Corporation, alongside its affiliated entities, delivers enterprise asset intelligence solutions globally within the automatic identification and data capture (AIDC) sector. Operating through its Asset Intelligence & Tracking and Enterprise Visibility & Mobility segments, the company provides a comprehensive suite of products and services. Its hardware lineup includes specialized printers for generating labels, wristbands, tickets, receipts, and plastic cards, alongside advanced dye-sublimation thermal card printers for secure identification and financial transactions, and RFID printers for data encoding. Complementing these are various accessories and essential consumables such as thermal labels, ribbons, RFID tags, and critical temperature-monitoring labels, notably used in vaccine distribution.…
Historical context
All ZBRA earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| WIT Wipro Limited | FY2027 Q2 · Calendar Q4 2026 | -25.0% | +3.9% | Wipro: AI pipeline expands as Q3 guidance stays narrow |
| TSM Taiwan Semiconductor Manufacturing Company Limited | FY2026 Q3 · Calendar Q4 2026 | +3.4% | -1.8% | TSMC beats Q3 guidance as AI demand drives fab expansion |
| ERIC Telefonaktiebolaget LM Ericsson (publ) | FY2026 Q3 · Calendar Q4 2026 | +28.6% | +11.8% | Ericsson Q3: 7% organic growth, resilient margins and AI-led demand |
Latest beats and misses
Who reports nextBeat on EPS
Missed on EPS
Get the ZBRA recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-02-06T00:01:56.136176+00:00
- Polygon adjusted daily market bars · 2026-10-19T12:40:42.281094+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-19T12:40:42.278270+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-19. For educational purposes only; not investment advice.